Statins and prostate cancer prevention: where we are now, and future directions

  • Murtola T
  • Visakorpi T
  • Lahtela J
 et al. 
  • 2

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Statins are cholesterol-lowering drugs that are widely used to prevent and treat atherosclerotic cardiovascular disease. Recent research from both in vitro and in vivo studies suggests that there is an association between the use of statins and a reduction in the incidence of and mortality from prostate cancer. Several mechanisms of action that might bring about these beneficial effects of statins have been proposed, most of which include direct effects of statins on intracellular signaling. In this Review we discuss the current knowledge on the use of statins to prevent prostate cancer. We will also look at future directions for clinical research on this topic.

Author-supplied keywords

  • Animals
  • Apoptosis/physiology
  • Cardiovascular Diseases/epidemiology/prevention &
  • Cell Cycle/physiology
  • Comorbidity
  • Disease Progression
  • GTPase-Activating Proteins/physiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors/adm
  • Hypercholesterolemia/drug therapy/epidemiology
  • Male
  • Meta-Analysis as Topic
  • Mevalonic Acid/therapeutic use
  • Prostate-Specific Antigen/blood
  • Prostatic Neoplasms/diagnosis/epidemiology/*preven
  • dosage/pharmacology/*therapeutic use
  • ras GTPase-Activating Proteins/physiology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Authors

  • T J Murtola

  • T Visakorpi

  • J Lahtela

  • H Syvala

  • TLj Tammela

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free